ArticleInternational archives of allergy and immunology2026

Long-Term Real-World Outcomes in Patients with Hereditary Angioedema Receiving Lanadelumab for 3 or More Years.

William R Lumry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.